SCHEMBL21149232

SCHEMBL21149232

c1ccc(-c2ccc(-c3nc(-c4cccc5c4sc4ccccc45)nc(-c4cccc5sc6ccccc6c45)n3)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.45
LIMK1 P53667 3/20 0.37
PARP14 Q460N5 1/20 0.37
GPR3 P46089 1/20 0.36
PRKDC P78527 4/20 0.34
PIK3CD O00329 1/20 0.34
PIK3CB P42338 1/20 0.34
TSHR P16473 2/20 0.34
ADORA2A P29274 2/20 0.34
ADORA1 P30542 2/20 0.34
ADORA3 P0DMS8 1/20 0.34
ALOX15 P16050 1/20 0.34
ADORA2B P29275 1/20 0.34
TNKS O95271 1/20 0.34
TNKS2 Q9H2K2 1/20 0.34
MAPT P10636 2/20 0.33
ATM Q13315 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20983142 0.97 ALOX5 (0.44) ALOX5LIMK1PARP14GPR3PRKDC
SCHEMBL26080437 0.96 ALOX5 (0.45) ALOX5LIMK1PARP14GPR3PRKDC
SCHEMBL21149180 0.96 ALOX5 (0.44) ALOX5LIMK1PARP14GPR3PRKDC
SCHEMBL23349700 0.95 ALOX5 (0.42) ALOX5LIMK1PARP14GPR3PRKDC
SCHEMBL24230957 0.95 ALOX5 (0.47) ALOX5LIMK1PARP14GPR3PRKDC
SCHEMBL22330284 0.95 ALOX5 (0.46) ALOX5LIMK1PARP14GPR3PRKDC
SCHEMBL22700534 0.95 ALOX5 (0.46) ALOX5LIMK1PARP14GPR3PRKDC
SCHEMBL22700552 0.95 LIMK1 (0.40) ALOX5LIMK1PARP14GPR3PRKDC
SCHEMBL26080440 0.94 ALOX5 (0.45) ALOX5LIMK1PARP14GPR3PRKDC
SCHEMBL25050524 0.94 ALOX5 (0.44) ALOX5LIMK1PARP14GPR3PRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO LTD (KR) 2023-10-12 US disclosed
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO LTD (KR) 2023-10-12 US disclosed
US-20190214573-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190214573-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 ALOX5 306/4885LIMK1 133/4885PARP14 4873/4885
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 ALOX5 306/4885LIMK1 133/4885PARP14 4873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.